ABSTRACT

Imaging technologies are receiving much attention in the pharmaceutical industry because of their potential for accelerating drug discovery and development. Magnetic Resonance (MR) Imaging is one of the principal modalities since it allows anatomical, functional, metabolic, and to a certain extent even target-related information to be gathered in v

chapter 5|20 pages

Rapid Phenotyping of Mice with MRI

chapter 7|12 pages

Imaging Alzheimer’s Disease with MRI

chapter 9|24 pages

MRI in Clinical Studies of Stroke

chapter 26|18 pages

MRI in Pharmaceutical Safety Assessment